The Hazelden Betty Ford Foundation today announced plans to expand into the Seattle area with a new addiction treatment center in Bellevue, Wash.
| CENTER CITY, Minn., /PRNewswire/ -- The Hazelden Betty Ford Foundation today announced plans to expand into the Seattle area with a new addiction treatment center in Bellevue, Wash. The new outpatient facility--to be named Hazelden Betty Ford in Bellevue--will be the national nonprofit addiction treatment leader’s 15th clinical site and will employ eight people initially. It is targeted to open in late January 2019, with a public ribbon cutting a month later. “This expansion will enable us to help many more people who are suffering from the disease of addiction, and will bolster our overall presence significantly on the West Coast,” said Mark Mishek, president and CEO of the Hazelden Betty Ford Foundation, which also has three sites in California and two in Oregon. “We heard from a number of Seattle-area business and healthcare leaders, who said additional quality treatment services were needed to meet swelling demand brought on by the opioid overdose epidemic and broader addiction crisis,” Mishek added. “We look forward to working with local partners to meet that need and to help build a strong culture of recovery and health in Bellevue and greater Seattle-Tacoma.” Hazelden Betty Ford’s new site will provide a full range of outpatient services for adults, along with “screening, brief intervention and referral to treatment” (SBIRT) services for teens. Services will include daily group-therapy sessions, opioid-specific support groups, individual counseling, family therapy, mental health services, and prescriptions for patients engaged in medication-assisted treatment. “The local leaders who invited us into the area identified a specific need for medication-assisted treatment services to help individuals and families affected by opioid addiction,” Mishek said. “We’ll be bringing in an innovative framework that we call our Comprehensive Opioid Response with the Twelve Steps, or COR-12™. It combines the use of medications, evidence-based clinical therapies and peer support to help people suffering from opioid use disorder not only stabilize but begin to transform their lives and get established in long-term recovery.” The new outpatient center in Bellevue will be part of the Overlake Medical Pavilion (1231 116th Ave NE), which is next door to Overlake Medical Center, a 349-bed nonprofit hospital, and has a diverse population of 1.8 million people living within 15 miles of it. The Pavilion is easily accessible via public transportation, including a nearby light rail stop currently under construction. The Seattle-Tacoma-Bellevue metropolitan area is the 15th largest market in the United States and is home to several large business headquarters, including Amazon, Microsoft, Costco and Starbucks. It is a three-hour drive from the Portland, Ore., area, where Hazelden Betty Ford operates facilities in Newberg and Beaverton. “We already receive a lot of patients from the Seattle area at our residential site in Newberg,” Mishek said. “Now that we’ll be able to help them transition to outpatient services in their home area, we think Newberg will become even more attractive to people in Seattle who need that level of care. With this new site, we look forward to becoming an even more vital source of healing and hope for individuals, families and communities throughout the Pacific Northwest.” About the Hazelden Betty Ford Foundation
View original content to download multimedia:http://www.prnewswire.com/news-releases/hazelden-betty-ford-foundation-to-open-addiction-treatment-center-in-seattle-area-300715551.html SOURCE Hazelden Betty Ford Foundation |
